Does obesity and diabetes mellitus metastasize to the brain? "Metaboptosis" and implications for drug discovery and development.
作者信息
McIntyre Roger S, Rong Carola, Mansur Rodrigo B, Brietzke Elisa
机构信息
Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada.
Brain and Cognition Discovery Foundation, Toronto, ON, Canada.
出版信息
CNS Spectr. 2019 Oct;24(5):467-469. doi: 10.1017/S1092852918001670.
PMID:30940233
Abstract
摘要
相似文献
1
Does obesity and diabetes mellitus metastasize to the brain? "Metaboptosis" and implications for drug discovery and development.肥胖症和糖尿病会转移至脑部吗？“代谢性凋亡”及其对药物研发的意义。
CNS Spectr. 2019 Oct;24(5):467-469. doi: 10.1017/S1092852918001670.
2
Advancement of Technology for Drug Discovery and Development - Part II.药物发现与开发技术进展 - 第二部分。
Curr Top Med Chem. 2020;20(1):3. doi: 10.2174/156802662001200122123740.
3
Receptor variants and the development of centrally acting medications
.受体变体与中枢作用药物的研发
Dialogues Clin Neurosci. 2019;21(2):149-157. doi: 10.31887/DCNS.2019.21.2/dbertrand.
4
Novo sets sights on obesity market with diabetes drug.诺和诺德凭借糖尿病药物瞄准肥胖症市场。
Nat Biotechnol. 2014 Nov;32(11):1071-2. doi: 10.1038/nbt1114-1071.
5
Medicinal chemistry of glucagon-like peptide receptor agonists.胰高血糖素样肽受体激动剂的药物化学
Prog Med Chem. 2013;52:45-96. doi: 10.1016/B978-0-444-62652-3.00002-8.
6
[The biguanides].
Policlinico Prat. 1967 Oct 2;74(40):1368-71.
7
The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship.利用肠促胰岛素激素的生理和药理特性开发具有令人信服的效益风险关系的糖尿病药物的跌宕起伏的历史。
Metabolism. 2020 Feb;103:154031. doi: 10.1016/j.metabol.2019.154031. Epub 2019 Nov 28.
8
Natural compound renews hope for diabetes and obesity therapeutic target.天然化合物为糖尿病和肥胖症治疗靶点带来新希望。
Future Med Chem. 2015;7(7):833-5. doi: 10.4155/fmc.15.40.
9
[Treatment of the adipose senile diabetic using Silubin retard].
Munch Med Wochenschr. 1966 May 13;108(19):1063-8.
10
Implications of sex-related differences in central nervous system disorders for drug research and development.中枢神经系统疾病中性别相关差异对药物研发的影响。
Nat Rev Drug Discov. 2021 Dec;20(12):881-882. doi: 10.1038/d41573-021-00115-6.
Zotero 插件